Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
autologous cultured fibroblasts (SCARM Institute)
- Development stage
- Unknown
- Lead developer
- SCARM Institute
- Modality
- Cell Therapies
- Administration
- Intradermal
01
Overview
This autologous cultured fibroblast therapy is a regenerative medicine product developed by the Stem Cell and Regenerative Medicine (SCARM) Institute in Tabriz, Iran. It is specifically designed for the correction of nasolabial folds and the mitigation of skin aging. The treatment process involves harvesting a small skin sample from the patient's retro-auricular area, from which fibroblasts are isolated and expanded in vitro. These cultured cells are then re-injected into the patient's dermal layers at the site of wrinkles or folds. The therapeutic mechanism relies on the transplanted fibroblasts' ability to synthesize essential extracellular matrix components, primarily collagen, thereby increasing dermal thickness and density to restore skin elasticity and volume.
- Other names
- autologous cultured fibroblasts-SCARM Institute, Tabriz, Iran-nasolabial folds-skin agingAutologous Fibroblast for Nasolabial FoldsFibroblast
Beyond the preview
Go deeper on autologous cultured fibroblasts (SCARM Institute).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on autologous cultured fibroblasts (SCARM Institute).